Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis

BACKGROUND: Use of menopausal hormonal therapy (MHT)-containing estrogen and a synthetic progestin is associated with an increased risk of breast cancer. It is unclear if progesterone in combination with estrogen carries a lower risk of breast cancer. Limited data suggest differences between progest...

Descripción completa

Detalles Bibliográficos
Autores principales: Asi, Noor, Mohammed, Khaled, Haydour, Qusay, Gionfriddo, Michael R., Vargas, Oscar L. Morey, Prokop, Larry J., Faubion, Stephanie S., Murad, Mohammad Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960754/
https://www.ncbi.nlm.nih.gov/pubmed/27456847
http://dx.doi.org/10.1186/s13643-016-0294-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960754/
https://www.ncbi.nlm.nih.gov/pubmed/27456847
http://dx.doi.org/10.1186/s13643-016-0294-5

Ejemplares similares